RECYTE THERAPEUTICS
BioTime, Inc. (NYSE Amex: BTX) is a biotechnology company developing products in the emerging field of regenerative medicine using stem cell technology. The Company has isolated over 140 diverse, scalable, and proprietary progenitors to the cell types in the human body. The numerous uses of these cells to regenerate tissue function are being developed through disease-focused subsidiaries of BioTime. ReCyte Therapeutics is one such subsidiary focused on applying the Company's proprietary ReCyteâ... „¢ technology to blood and vascular aging. ReCyteâ„¢ is a technology capable of reprogramming cells taken from aged patients back to an embryonic state such that all cell types can be produced genetically identical to the patient. It is also capable of resetting the telomere clock of cellular aging to make any type of young cells otherwise identical to aged patients. ReCyte's mission is to pioneer the application of this advance in gerontology to the largest unmet need in aging; namely cardiovascular and blood senescence.
RECYTE THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2007-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.recyte.com
Total Employee:
1+
Status:
Closed
Contact:
510-521-3390
Email Addresses:
[email protected]
Total Funding:
9.9 M USD
Technology used in webpage:
Google Maps Google Google Cloud Amazon Route 53 Pound Sterling Japanese Yen Google Cloud South Carolina
Current Employees Featured
More informations about "ReCyte Therapeutics"
ReCyte Therapeutics - Crunchbase Company Profile & Funding
ReCyte Therapeutics is one such subsidiary focused on applying the Company's proprietary ReCyteâ„¢ technology to blood and vascular aging. ReCyteâ„¢ is a technology capable of …See details»
ReCyte Therapeutics - Craft
ReCyte Therapeutics is a regenerative medicine company focused on the repair of vascular disorders including both age-related diseases and injuries. Its products are derived from …See details»
Recyte Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Recyte Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
ReCyte Therapeutics Inc - Company Profile and News
ReCyte Therapeutics Inc. offers products in the field of regenerative medicine using stem cell technology. The Company develops therapies for age-related cardiovascular and blood …See details»
ReCyte Therapeutics - Funding, Financials, Valuation & Investors
ReCyte Therapeutics is a regenerative medicine company focused on stem cell technology.See details»
ReCyte Therapeutics, Inc. - VentureRadar
Find out more about ReCyte Therapeutics, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Stem cell breakthroughs within Cyte? | Drug Discovery News
Oct 10, 2011 · ReCyte targets age-related vascular disease, and OncoCytewill use the technology to find a way to deliver a toxic payload to canceroustumors. The work at both spinoffs relies on …See details»
ReCyte Therapeutics - Tech Stack, Apps, Patents & Trademarks
ReCyte Therapeutics is a regenerative medicine company focused on stem cell technology.See details»
ReCyte Therapeutics CEO and key executive team | Craft.co
ReCyte Therapeutics's CEO is Michael D West. Other executives include Judith Segall, Corporate Secretary. See the full leadership team at Craft.See details»
ReCyte Therapeutics, Inc., A BioTime Subsidiary, Announces
May 6, 2016 · ALAMEDA, Calif.--(BUSINESS WIRE)--ReCyte Therapeutics, a subsidiary of BioTime, Inc., a clinical-stage regenerative medicine company with a focus on pluripotent stem …See details»
ReCyte Therapeutics - VentureRadar
We are proud to offer Contract Development and Manufacturing Organization (CDMO) services for biopharmaceutical companies to propel your important monoclonal antibody molecules …See details»
ReCyte Therapeutics and OncoCyte Corporation Release
Jan 24, 2012 · Scientists at BioTime’s subsidiaries OncoCyte Corporation and ReCyte Therapeutics plan to apply this technology in the development of innovative medical products …See details»
Dana Larocca - AI Ecosystem
At ReCyte Therapeutics, she served as VP of Research and Development. She was founder and CEO of Mandala Biosciences, LLC where she raised over $3M in non-dilutive funding. Dr.See details»
ReCyte Therapeutics - Contacts, Employees, Board Members
ReCyte Therapeutics is a regenerative medicine company focused on stem cell technology.See details»
Research programme: age-related cardiovascular and blood …
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
BioTime Announces Additional Products in Development Based on …
Oct 4, 2013 · ReCyte Therapeutics, Inc. is developing therapies to treat a variety of blood and lymphatic vascular disorders, as well as products for research using iPS and other cell …See details»
David Larocca | Recyte Therapeutics | United States of America
David Larocca joined ReCyte Therapeutics, Inc. as Vice President of Research and Development in September 2013. He previously founded Mandala Biosciences, LLC, where he served as …See details»
Home - Recyte AI
Recyte offers AI-powered chat to recall every detail of your documents, whenever you need them. Easily access the information that you and others need but can't remember, to stay organized …See details»
The Noble Quran - Quran.com
Follow the Global Quranic Calendar for weekly readings, inspiring podcasts, and a call to reflect! Read, study, and learn The Noble Quran. Quran.com is a Sadaqah Jariyah. We hope to make …See details»
Recite: APA and Harvard citations checked instantly
Very simply, Recite checks that your in text citations match the reference list at the end of your work. First, Recite checks that the authors and dates in the body of your work match up with …See details»